7498 Results (Page 235 of 300)
Pharmaceuticals Markets Research Reports
Poland ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Poland's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $171 Mn in 2022 to $316 Mn in 2030 with a CAGR of 7.95% for the year 2022-2030. The increased prevalence of ADHD and the availability of novel therapeutic options for the treatment of ADHD in Poland are the major market drivers for the growth of the market. The Poland ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market are ALG Pharma, Techdow Pharma, and Noven Pharmaceuticals.
Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Netherlands' Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $77 Mn in 2022 to $142 Mn in 2030 with a CAGR of 8% for the year 2022-2030. The increasing awareness of ADHD in the Netherlands and the constant development of newer therapeutic options in the Netherlands market are the major growth drivers of the market. The Netherlands ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key competitors in the market are Synerkine Pharma, Caldic, and Neurovance.
Mexico ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Mexico's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $443 Mn in 2022 to $806 Mn in 2030 with a CAGR of 7.75% for the year 2022-2030. Major factors responsible for the expansion of the market are an increase in ADHD prevalence in Mexico and the Mexican government’s initiatives to provide novel therapeutic options for ADHD treatment. The Mexico ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmacia Regina, Farmacia San Martin, and Shire are the key players in the market.
Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Vietnam's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $148 Mn in 2022 to $268 Mn in 2030 with a CAGR of 7.73% for the year 2022-30. The rise in urbanization in Vietnam leading to the increased incidence of ADHD among the school-going population and increasing investments in the healthcare infrastructure are the major market drivers. The Vietnam ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. ImexPharm Pharmaceutical, Binh Dinh Pharmaceutical, and Eli Lily are the leading players in the market.
UAE ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
UAE's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $148 Mn in 2022 to $284 Mn in 2030 with a CAGR of 8.5% for the year 2022-30. More cases of ADHD being diagnosed in children and UAE and the development of health infrastructure in UAE are the main market drivers. The UAE ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Join Hub Gulf Pharma, Genpharm, and Eli Lilly are some of the key players in the market.
Thailand ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Thailand's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $35 Mn in 2022 to $65 Mn in 2030 with a CAGR of 7.84% for the year 2022-30. The increase in the disposable incomes of the population in Thailand and the rising demand for effective treatment options for ADHD in Thailand are propelling the market growth. The Thailand ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the leading companies in the market are Healol Pharmaceuticals, Sriprasit Pharmacy, and Prude Pharma.
Philippines ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Philippines Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to witness growth from $65 Mn in 2022 to $120 Mn in 2030 with a CAGR of 8% for the year 2022-30. The increase in ADHD awareness in the Philippines as a result of various government initiatives to spearhead information about ADHD is the major growth driver of the market. The Philippines ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmacia Medica, Phil Pharmawealth, and Eli Lily are some of the key players in the market.
Japan ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Japan's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $1.8 Bn in 2022 to $3.4 Bn in 2030 with a CAGR of 8% for the year 2022-30. This market growth is attributed to the rise in ADHD prevalence in Japan and consequently the demand for new drugs and their approvals. The Japan ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the leading players in the market include Kouken, Lupin, and Takeda Pharmaceuticals.
Italy ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Italy's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $709 Mn in 2022 to $1,219 Mn in 2030 with a CAGR of 7% for the year 2022-30. Increasing prevalence and the rise in demand for treatment options for ADHD in Italy are likely the growth drivers for the market expansion. The Italy ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmaka, Medac Pharma, and Alcobra are the key players in the market.
Indonesia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Indonesia's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $177 Mn in 2022 to $316 Mn in 2030 with a CAGR of 7.5% for the year 2022-30. The major market drivers include increasing awareness about the disorder and the availability of ADHD therapies in Indonesia. The Indonesia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Gratia Husada Farma, Etana Biotechnologies, and Noven Pharmaceuticals are the key players in the market.
India ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
India's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to grow from $538 Mn in 2022 to $1,195 Mn in 2030 with a CAGR of 10.5% for the year 2022-30. With a larger prevalence of ADHD in India than that globally, the ADHD therapeutics market in India has a lot of potential. The India ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Actiza Pharmaceutical, Ayursun Pharma, and Eli Lily are some of the key players in the market.
Germany ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Germany's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $1.08 Bn in 2022 to $1.68 Bn in 2030 with a CAGR of 5.7% for the year 2022-30. The major market drivers include rising awareness of the disorder and the increasing supply of ADHD drugs which include both stimulants and non-stimulants. The Germany ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the major competitors in the market are Adragos Pharma, Hermes Arzneimittel, and Shire.
France ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
France's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $813 Mn in 2022 to $1,345 Mn in 2030 with a CAGR of 6.5% for the year 2022-30. The increased prevalence of ADHD in France and rising investments in mental health services are the major market drivers for the growth of the market. The France ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Novasep, Poxel, and Adlon Therapeutics are the key players in the market.
Brazil ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Brazil's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to grow from $739 Mn in 2022 to $1,419 Mn in 2030 with a CAGR of 8,5% for the year 2022-30. The rising incidence of ADHD in Brazil and supportive government initiatives by the Brazilian government are responsible for the growth of the market. The Brazil ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market include Corporacion Bonima, Ovidio J. Vides, and Eli Lily.
Australia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Australia's ADHD therapeutics market is expected to witness growth from $355 Mn in 2022 to $707 Mn in 2030 with a CAGR of 9% for the year 2022-30. The increasing prevalence of ADHD in Australia and the rise in demand for innovative treatment options for its treatment and more investments by pharmaceutical companies in ADHD drugs are the potential growth drivers for the market. The Australia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Zucero Therapeutics, Atherton Pharmaceuticals, and Novartis are the major players operating in the market.
Vietnam Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Vietnam Liver Disease Therapeutics market will reach a value of $183 Mn from $115 Mn in 2022, growing at a CAGR of 5.9% during 2022-2030. Liver Disease Therapeutics in Vietnam is dominated by domestic pharmaceutical companies such as Domesco, Ha Tay Pharmaceutical, and OPC. The Liver Disease Therapeutics market in Vietnam is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Vietnam Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UAE Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Liver Disease Therapeutics market will reach a value of $194 Mn from $115 Mn in 2022, growing at a CAGR of 6.7% during 2022-2030. Liver Disease Therapeutics in UAE is dominated by domestic pharmaceutical companies such as Global pharma, Neopharma, and Julphar. The Liver Disease Therapeutics market in UAE is segmented into different types of disease and different therapy types. Some of the significant factors affecting the UAE Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Japan Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Japan Liver Disease Therapeutics market will reach a value of $2.3 Bn from $1.4 Bn in 2022, growing at a CAGR of 6.2% during 2022-2030. Liver Disease Therapeutics in Japan is dominated by domestic pharmaceutical companies such as Aspen Pharmacare Japan, Mayne Pharma, and Phebra. The Liver Disease Therapeutics market in Japan is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Japan Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
India Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the India Liver Disease Therapeutics market will reach a value of $818 Mn from $420 Mn in 2022, growing at a CAGR of 8.7% during 2022-2030. Liver Disease Therapeutics in India is dominated by domestic pharmaceutical companies such as Dr. Reddy's Laboratories, Cadila Healthcare, and Sun Pharmaceutical. The Liver Disease Therapeutics market in India is segmented into different types of disease and different therapy types. Some of the significant factors affecting the India Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Egypt Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Liver Disease Therapeutics market will reach a value of $113 Mn from $65 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Egypt is dominated by domestic pharmaceutical companies such as Pharco Pharmaceuticals, Delta Pharma, and EIPICO. The Liver Disease Therapeutics market in Egypt is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Egypt Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Brazil Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil Liver Disease Therapeutics market will reach a value of $970 Mn from $577 Mn in 2022, growing at a CAGR of 6.7% during 2022-2030. Liver Disease Therapeutics in Brazil is dominated by domestic pharmaceutical companies such as Eurofarma, Aché Laboratórios, and EMS. The Liver Disease Therapeutics market in Brazil is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Brazil Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Australia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Liver Disease Therapeutics market will reach a value of $483 Mn from $277 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare Australia, Mayne Pharma, and Phebra. The Liver Disease Therapeutics market in Australia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Australian Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UK Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UK Liver Disease Therapeutics market will reach a value of $803 Mn from $600 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. Liver Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as Intercept Pharmaceuticals, Gilead Sciences, AstraZeneca and Shire. The Liver Disease Therapeutics market in the UK is segmented into different types of disease and different therapy types. Some of the major factors affecting the UK Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Turkey Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Turkey Liver Cancer Therapeutics market will reach a value of $88.7 Mn from $23.4 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. Liver Cancer Therapeutics in Turkey is dominated by a few domestic pharmaceutical companies such as Nobel İlaç, Mustafa Nevzat Pharmaceuticals and Deva Holding. The Liver Cancer Therapeutics market in Turkey is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Turkey Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Thailand Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Thailand Liver Cancer Therapeutics market will reach a value of $13.2 Mn from $3.52 Mn in 2022, growing at a CAGR of 17.9% during 2022-2030. Liver Cancer Therapeutics in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, Mega Lifesciences and Bangkok Hospital. The Liver Cancer Therapeutics market in Thailand is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Thailand Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
